J&J Can't Revive Claims Against Abbott, Boston Sci
By Abigail Rubenstein ( February 18, 2010, 3:02 PM EST) -- A federal judge has ruled that Johnson & Johnson cannot amend its complaint to resurrect its breach of contract and anti-competitive conduct claims against Abbott Laboratories and Boston Scientific Corp. in a $5.5 billion suit over its failed bid to acquire Guidant Corp....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.